Cluster-randomized Trial to Evaluate the Impact of Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response

Trial Profile

Cluster-randomized Trial to Evaluate the Impact of Ciprofloxacin for Contacts of Cases of Meningococcal Meningitis as an Epidemic Response

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Meningococcal meningitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 23 Apr 2017 Planned End Date changed from 1 Jul 2017 to 31 Dec 2017.
    • 23 Apr 2017 Planned primary completion date changed from 1 May 2017 to 30 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top